Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine
This cohort study compares the incidence of cardiovascular disease between Medicare beneficiaries with migraine who initiated anti–calcitonin gene-related peptide (CGRP) monoclonal antibodies compared with onabotulinumtoxinA.